Table 3. Birth Outcomes among HIV positive women who received or did not receive PMTCT prophylaxis or HAART (eligibility based on available CD4 count).

	PMTCT Eligible and Received PMTCT AZT/NVP* (n-216)	HAART Eligible and received HAART (n = 58)	HAART Eligible but did not receive HAART (n = 141)	Total N = 415	Adjusted Odds Ratio (95%CI)	p value
Preterm	2 (1.6%)	34 (26.6%)	92 (71.9%)	128 (31.1%)	0.73 (0.4–1.4)	0.20
Term	212	24	48	284
Stillbirths	1 (9.0%)	1 (9.0%)	9 (81.8%)	11 (2.7%)	0.23 (0–1.4)	0.11
Live Births	213	57	131	401
Birthweight <2500 g	3 (27%)	4 (36.4%)	4 (36.4%)	11 (2.7%)	1.03 (0.4–2.0)	0.53
Birthweight ≥2500 g	211	54	136	401

*Only 2 women did not receive PMTCT prophylaxis AZT/NVP. Excluded all other women who received PMTCT prophylaxis but their eligibility for HAART was unknown (CD4 count unknown).